Derma Sciences closes $36.4M public offering; Alere turns to J&J for new COO;

 @FierceMedDev: Medtronic facing federal suit from 'exploited' patients. Story | Follow @FierceMedDev

@MarkHFierce: Cerapedics pulled in a $19M Series C for its bone graft development work. New investors include MedImmune. More | Follow @MarkHFierce

 @DamianFierce: Welch Allyn isn't done reorganizing. After announcing plans to cut 275 jobs, it's moving its Euro HQ. Article | Follow @DamianFierce

> AdvaMed board chairman James Mazzo, head of Abbott Medical Optics, said he believes the medical device tax won't be repealed any time soon. Story

> Derma Sciences ($DSCI) closed a $36.4 million public offering, with plans to use the money to fuel development of its treatment for diabetic foot ulcers. Release

> Intuitive Surgical ($ISRG) plans its 2012 fourth-quarter earnings call for Tuesday, Jan. 22. Release

> Bausch & Lomb's investors may sell the company outright rather than pursue an IPO, thanks to steady attention from potential inquirers such as Sanofi ($SNY) and Merck ($MRK). Story

> Misonix, a maker of ultrasonic surgical tools, ended its distribution agreement with Aesculap for the company's BoneScalpel ultrasonic bone-cutting system and will instead sell the product directly. Item

> Diagnostics company Alere ($ALR) named veteran Johnson & Johnson ($JNJ) executive Namal Nawana as its new chief operating officer. Release

Biotech News

 @FierceBiotech: Nuron acquires Pfizer's meningitis vaccine. Story | Follow @FierceBiotech

@JohnCFierce: What does Lilly have? A signal, unconfirmed, that solanezumab works in mild Alzheimer's. See you in 3-4 years, alongside much competition. | Follow @JohnCFierce

@RyanFierce: Gilead wants a piece of the big oncology pie, as it showed with the Yale deal last year. YM could get it there sooner. Report | Follow @RyanMFierce

> GlaxoSmithKline ($GSK) backs upstart's $17M A round for therapy against bulging-eye ailment. Article

> Eli Lilly ($LLY) ditches FDA filing for Alzheimer's hope solanezumab. News

Pharma News

@FiercePharma: Sanofi, Merck, others said to be eyeing Bausch buyout. Story | Follow @FiercePharma

> French drug exec charged with manslaughter over drug safety. News

> Levin lays out 4-year plan to turn Teva into a brand. Article

Drug Delivery News

> Eleven's lead topical eye drug completes PhIa, enters PhIb trials. Report

> Silver bullet targets antibiotics to deep infections. News

> Porcupine quills point to less painful shots. Story

> Sirtex, SingHealth develop stealth cancer treatments. Article

> Alnylam ($ALNY) plans clinical trials for RNAi therapeutic. More

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.